Bond And Money Market

We present a matrix detailing some movement in some key market rates (domestic and global) and key events:

Parameters 31-August-21 30-July-21 31-August-20
RBI Repo Rate % 4.00 4.00 4.00
5Y AAA PSU % 5.87 6.01 5.61
1 year CD % 4.22 4.02 3.83
10Y Gsec % 6.22 6.20 6.08
CPI (%) 5.59 6.26 6.93
IIP (YoY) % 13.62 29.27 -16.6
US 10Y % 1.31 1.22 0.70
Dollar Rupee 73.01 74.42 73.13

Source: Bloomberg; Data as on August 31, 2021

The debt markets remained steady with a dovish bias through the month. The MPC which had met during the first week of August reaffirmed a continued accommodative stance. Globally the Jackson Hole address by the US Fed Governor Jerome Powell largely assuaged the market participants as he commented about “reduction in asset purchases will not be intended to carry a direct signal regarding the timing of interest rate liftoff, for which we have articulated a different and substantially more stringent test”; essentially implying an unhurried approach to raising the Fed Reserve rates. This buoyed domestic sentiments too and markets saw a fall in bond and gsec rates. Further strong GST collection also helped the sentiments in the market as market set in expectations of a possibly lower Central Government borrowing. The comfortable interbank liquidity helped the money market rates to drift lower.

The First Quarter Real GDP number growth was printed at 20.10% and was moderately below market expectations. While all sectors recorded strong growth due to the base effects, it is sobering to realize that compared to the pre pandemic GDP of First quarter of FY 20 , only Agriculture sector has recorded a positive growth whereas the services sector ,which dominates the economy is still at level lower than the pre pandemic levels , showing deep scars left by the pandemic on the economy . The CPI inflation was printed at 5.59 % with core inflation continuing to print high numbers.

Looking Ahead
  • We remain apprehensive of a gradual rate rise as we move through the year. We remain apprehensive of a commodity prices rise induced inflation and a gradual normalization in the economy leading to the rate rise.
  • The possibility of a bear flattening of the yield curve exists with long term rates rising lesser than short term rates
  • We also believe that AAA credit spreads are very tight and the probability of spreads to increase in the near future remains a distinct possibility
  • Liquidity being in sustained surplus mode, the extreme short end of the yield curve may remain stable.
Scheme Specific Strategies for Debt schemes
  • Mahindra Manulife Low Duration Fund
  • Mahindra Manulife Ultra Short Term Fund
    • The average maturity of the portfolio is around 3.72 months
    • We aim to maintain the maturity as we move ahead through the next month
    • The YTM of the portfolio is around 3.71%
    • With surplus liquidity conditions we expect the extreme short end money market rates to remain benign
  • Mahindra Manulife Liquid Fund
    • We continue to maintain a healthy mix of certificate of deposits and commercial papers
    • We will attempt to ensure adequate liquidity, safety and accrual
  • Mahindra Manulife Dynamic Bond Yojana
    • The YTM of the portfolio has decreased to around 5.40%.
    • The Modified Duration of the portfolio (MD) decreased to around 4.86
    • While we have decreased our duration of our portfolio, we intend now to remain steady at these levels
  • Mahindra Manulife Short Term Fund
    • The YTM of the portfolio is around 4.92%
    • The Modified duration of the portfolio increased to 2.18
    • Our portfolio continues to have a large allocation towards gilts, accounting for around 60 % of the duration as we are wary of the spreads increasing in AAA credits
Equity Market

We present a summary of changes in key Indian & Global equity indices


S&P BSE Sensex Nifty 50 BSE Midcap BSE Small Cap Nifty Midcap 100 Nifty Small Cap 100 Dow Jones Indus. Avg S&P 500 Index Nasdaq Composite Index
1 Mth Performance 9.4% 8.7% 3.3% 0.5%% 2.2% -2.5% 1.2% 2.9% 4.0%
1 Yr Performance 49.0% 50.4% 62.7% 87.8% 70.3% 83.6% 24.4% 29.2% 29.6%

Source: Bloomberg Performance - Absolute returns | Data as on August 31, 2021

Indian markets changed track after a long time with leadership shifting to large caps, Nifty driving the markets while small caps actually turning negative (Nifty small cap 100) for the month. Some kind of mean reversion has been expected post a stupendous rally in small caps from last year lows. The markets remain driven by the increasing retail participation in equity markets, both directly as well as through mutual fund schemes while FPIs were net sellers remained during the month. Among large sectors in market; IT, Financial Services (NBFCs mainly) and FMCG outperformed NIFTY while all other sectors underperformed Nifty.

Globally, the equity markets continue to remain in positive zone, with key exceptions being China and Hong Kong. On an incremental basis, the newsflow has started becoming less positive on both economy as well as covid front. While vaccination led opening up in USA has happened, covid cases have started rising again in USA with delta variant being the cause. On economy, the supply disruptions, led by semiconductor and logistics have been driving inflation as well as camouflaging the excess demand. While auto companies are leading the brunt on semiconductor shortfall, even consumer electronics and durables are being impacted. As shipping time rising, there is an issue of adequate availability of many other goods (independent of semiconductor). It is becoming tougher globally to estimate whether demand surge is due to more consumers or less production.

While there remains a status quo from the US Federal Reserve on policy action, directionally they have indicated a path towards reducing the quantum of liquidity infusion in CY21 itself. While this is more a reduction in pace of infusion rather than an actual unwinding of liquidity, this could matter in a liquidity driven world, where investors are adding 80-90 bn$ (monthly average in CYTD21) towards equity assets. One disturbing sign has been the extent of flows (globally) moving towards ETF’s (80%+ in this CYTD21). The underlying issue with ETFs remain the lack of any informed investment decision making (valuation agnostic). On the same subject of US Fed and monetary policy, it would be interesting to observe market behaviour when tapering starts. It is a tough call to decode what has been the key driver of global risk appetite for equity assets, whether it’s the comfort of liquidity infusion or low rates. Next 6 months, would provide some clarity on whether liquidity or low rates drive investor behaviour.

In India’s context, GDP data for Q1FY22 came at 20.1% growth on a bad base of Q1FY21. In absolute terms, however, GDP for Q1FY22 is lower than Q1FY20 (two years) and that’s something to reflect upon in terms of market valuation. While markets have been driven by formalisation where corporates have been gaining market share (and profitability), at some stage we do need a bigger support from overall GDP growth. On the whole, the focus on PLI scheme and Aatmanirbhar Bharat are expected to create domestic value addition (via import substitution as well as export growth) over medium term and may help on GDP front as India is likely to move towards 3rd largest country in GDP terms in this decade.

India continues to vaccinate well with reports of having administered reaching nearly 1 crore vaccination in a single day. Clearly the expectations of economic recovery and market sentiments are based on successful post-vaccination normalisation and not factoring wave 3 of covid.

Looking Ahead

The policy action in USA on both monetary and fiscal front remains key economic variables that can drive market sentiments as majority gains have accrued on valuations arising from lower interest rates. We await USA’s fiscal policy response in September.

The result season for Q1FY22 has been good though the base effect makes any comparison with FY21 not very relevant. We remain optimistic about, FY22 likely to be a replay of FY21 where economy normalised during Q3 festive season in Q3. However, global supply disruptions are likely to hurt the earlier expectations about pace of growth.

While the power of asset allocation to equity in past 12-15 months has been seen, it is time for investors to focus on asset allocation and keep the discipline. As markets are scaling newer highs driven by more by valuations (discounting longer term horizon) and less by near term earning visibility, it is equally important for investors to have a similar time frame while investing. On a market capitalisation front, we remain more positive on large cap as an overall segment without taking away relevance of any stock specific bottom up ideas in mid and small cap, that can grow faster in rapidly changing economy.

Investors with lumpsum investments style could have an asset allocation strategy (equity as a % of portfolio) to try and benefit from greed and fear phases. Alternately, the strategy could be to really stick to longer term outlook rather than focussing on 1-2 years volatility. For investors with SIP investments however such phases are not so relevant as investor is still in accumulation phase for wealth creation over the 5-7 years. SIP may be a good alternate to avoid the behavioural traps during the extreme phases of markets. We maintain that Investors use SIP as part of core investment philosophy and use the lumpsum route during the extreme phases to top-up on their SIPs during the fearful times amidst the volatility.

Source: Bloomberg

Scheme Specific Strategies for Equity schemes
  • Mahindra Manulife Multi Cap Badhat Yojana
  • Mahindra Manulife Mid Cap Unnati Yojana
  • Mahindra Manulife ELSS Kar Bachat Yojana
  • Mahindra Manulife Rural Bharat and Consumption Yojana
  • Mahindra Manulife Large Cap Pragati Yojana
  • Mahindra Manulife Top 250 Nivesh Yojana
  • Mahindra Manulife Focused Equity Yojana
Scheme Specific Strategies For Hybrid Schemes
  • Mahindra Manulife Equity Savings Dhan Sanchay Yojana
  • Mahindra Manulife Hybrid Equity Nivesh Yojana

    Equity:

    • Portfolio composition would have preference for growth style of investing.
    • Bottom-up approach would be adopted to identify companies that have ability to scale up, gain market share and/or are present in sunrise/high growth sectors.

    Debt:

    • The Modified duration of the portfolio is around 3.40 for the debt portion
    • We continue to have a larger allocation towards gilts and will maintain this stance in the near future.
What should an investor do?

For investments in debt oriented products:

  • We believe that the investors with a shorter investment horizon may continue investments in ultra-short term and low duration funds
  • For a medium to long term investment horizon and with a suitable risk appetite, an allocation to Short Term Fund and Dynamic Bond Fund merits attention.

For investments in equity oriented products:

  • Our view is that volatility may continue and SIP may be a good way to increase equity market allocations
  • Investors looking to invest for a medium to long period, can consider SIPs or STPs into focused, multicap or hybrid funds based on risk appetite.
  • Investors looking for a better return opportunity and with a suitable risk appetite, may consider part allocation in mid cap fund as well.
Scheme Name Product Suitability Riskometer
Mahindra Manulife Overnight Fund
An open ended debt scheme investing in overnight securities
This Product is suitable for investors who are seeking*:
  • To generate reasonable returns with high levels of safety and convenience of liquidity over short term
  • To invest in debt and money market instruments having maturity of upto 1 business day
Mahindra Manulife Arbitrage Yojana
An open ended scheme investing in arbitrage opportunities
This Product is suitable for investors who are seeking*:
  • Income over short term
  • Income through arbitrage opportunities between cash and derivative market and arbitrage opportunities within the derivative segment.
Mahindra Manulife Liquid Fund
An Open Ended Liquid scheme
This Product is suitable for investors who are seeking*:
  • Regular income over short term
  • Investment in money market and debt instruments
Mahindra Manulife Short Term Fund
An open ended short term debt scheme investing in instruments such that the Macaulay duration of the portfolio is between 1 year and 3 years (please refer to page no. 35 of SID)
This Product is suitable for investors who are seeking*:
  • Income over short to medium term.
  • Investment in debt and money market instruments.
Mahindra Manulife Low Duration Fund
An open ended low duration debt scheme investing in instruments such that the Macaulay duration of the Portfolio is between 6 months and 12 months (Please refer page 32 of SID)
This Product is suitable for investors who are seeking*:
  • Regular income over short term
  • Investment in debt and money market instruments
Mahindra Manulife Ultra Short Term Fund
An open ended ultra-short term debt scheme investing in instruments such that the Macaulay duration of the portfolio is between 3 to 6 months (please refer to page no. 32 of SID)
This Product is suitable for investors who are seeking*:
  • Regular Income over short term.
  • Investment in a portfolio of short term debt and money market instruments.
Mahindra Manulife Dynamic Bond Yojana
An open ended dynamic debt scheme investing across duration 
This Product is suitable for investors who are seeking*:
  • To generate regular returns and capital appreciation through active management of portfolio
  • Investments in debt & money market instruments across duration.
Mahindra Manulife Equity Savings Dhan Sanchay Yojana
An open ended scheme investing in equity, arbitrage and debt
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation and generation of income
  • Investment in equity and equity related instruments, arbitrage opportunities and debt and money market instruments
Mahindra Manulife ELSS Kar Bachat Yojana
An open ended equity linked saving scheme with a statutory lock in of 3 years and tax benefit
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation
  • Investment predominantly in equity and equity related securities
Mahindra Manulife Focused Equity Yojana
An open ended equity scheme investing in maximum 30 stocks across market caps (i.e Multi Cap)
This Product is Suitable for investors who are seeking*
  • Long term capital appreciation
  • Investment in equity and equity related instruments in concentrated portfolio of maximum 30 stocks across market capitalziation.
Mahindra Manulife Top 250 Nivesh Yojana
Large & Mid Cap Fund - An open ended equity scheme investing in both large cap and mid cap stocks
This Product is suitable for investors who are seeking*:
  • Long term wealth creation and income
  • Investment predominantly in equity and equity related securities of large and Mid cap companies.
Mahindra Manulife Multi Cap Badhat Yojana
Multi Cap Fund- An open ended equity scheme investing across large cap, mid cap, small cap stocks
This Product is suitable for investors who are seeking*:
  • Medium to Long term capital appreciation;
  • Investment predominantly in equity and equity related securities including derivatives.
Mahindra Manulife Mid Cap Unnati Yojana
Mid Cap Fund – An open ended equity scheme predominantly investing in mid cap stocks
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation;
  • Investment predominantly in equity and equity related securities including derivatives of mid cap companies
Mahindra Manulife Large Cap Pragati Yojana
Large Cap Fund - An open ended equity scheme predominantly investing in large cap stocks
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation;
  • Investment predominantly in equity and equity related securities including derivatives of large cap companies.
Mahindra Manulife Hybrid Equity Nivesh Yojana
An open ended hybrid scheme investing predominantly in equity and equity related instruments
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation and generation of income;
  • Investment in equity and equity related instruments and debt and money market instruments
Mahindra Manulife Rural Bharat and Consumption Yojana
An open ended scheme following Rural India theme
This Product is suitable for investors who are seeking*:
  • Long term capital appreciation;
  • Investment predominantly in equity and equity related securities including derivatives of entities engaged in and/ or expected to benefit from the growth in rural India.

* Investors should consult their financial advisers if in doubt about whether the product is suitable for them

The views expressed here in this material are for general information and reading purpose only and do not constitute any guidelines and recommendations on any course of action to be followed by the reader. No representation or warranty is made as to the accuracy, completeness or fairness of the information and opinions contained herein. The views are not meant to serve as a professional guide / investment advice / intended to be an offer or solicitation for the purchase or sale of any financial product or instrument or mutual fund units for the reader. This material has been prepared on the basis of publicly available information, internally developed data and other sources believed to be reliable. While utmost care has been exercised while preparing this material, Mahindra Manulife Investment Management Private Limited (formerly known as Mahindra Asset Management Company Private Limited) (AMC) does not warrant the completeness or accuracy of the information and disclaims all liabilities, losses and damages arising out of the use of this information. The data/statistics given in this material are to explain general market trends in the securities market, it should not be construed as any research report/research recommendation. Readers of this material should rely on information / data arising out of their own investigations and advised to seek independent professional advice and arrive at an informed decision before making any investments. Neither Mahindra Manulife Mutual Fund, the AMC nor Mahindra Manulife Trustee Private Limited (formerly known as Mahindra Trustee Company Private Limited), its directors or associates shall be liable for any damages that may arise from the use of the information contained herein.

Cno.01039

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.

MF banner